Table 1.
Clinical parameters | Overall (n = 145) | SKA1 protein expression | P value | |
---|---|---|---|---|
Low (n = 48) | High (n = 97) | |||
Gender | ||||
Male | 82 | 27 | 55 | .959** |
Female | 63 | 21 | 42 | |
Age (y) | ||||
Mean ± SD | 66.30 ± 9.431 | 65.59 ± 10.07 | 66.67 ± 9.12 | .602* |
>65(%) | 55.2 | 52.1 | 56.7 | .413** |
Grade | ||||
G1 | 102 | 33 | 69 | .767** |
G2 | 43 | 15 | 28 | |
T classification | ||||
T1 + T2 | 66 | 20 | 46 | .512** |
T3 + T4 | 79 | 28 | 51 | |
N classification | ||||
Absent | 94 | 31 | 63 | .207** |
Present | 17 | 3 | 14 | |
Metastasis | ||||
Yes | 7 | 2 | 5 | 1*** |
No | 138 | 46 | 92 | |
Tumour location of pancreas | ||||
Head and neck | 99 | 29 | 70 | .153** |
Body and tail | 46 | 19 | 27 | |
Nerve infiltration | ||||
Yes | 98 | 28 | 70 | .094** |
No | 47 | 20 | 27 | |
Vessel infiltration | ||||
Yes | 27 | 6 | 21 | .183** |
No | 118 | 42 | 76 | |
Tumour diameter (cm) | ||||
≤3 | 69 | 31 | 38 | .019** |
>3 | 76 | 20 | 56 |
Independent sample test.
Pearson chi‐squared test.
Continuity correction.